High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival.

MLA

Mező, Blanka, et al. “High-Activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-Specific Antibody-Triggered Injury and Renal Allograft Survival.” Transplantation Direct, vol. 6, no. 3, Feb. 2020, p. e534. EBSCOhost, https://doi.org/10.1097/TXD.0000000000000978.

APA

Mező, B., Reindl-Schwaighofer, R., Eskandary, F., Heinzel, A., Wahrmann, M., Doberer, K., Heilos, A., Bond, G., Kläger, J., Kozakowski, N., Haslacher, H., Oberbauer, R., Viklický, O., Hrubá, P., Halloran, P. F., Rusai, K., Prohászka, Z., & Böhmig, G. A. (2020). High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival. Transplantation Direct, 6(3), e534. https://doi.org/10.1097/TXD.0000000000000978

Chicago

Mező, Blanka, Roman Reindl-Schwaighofer, Farsad Eskandary, Andreas Heinzel, Markus Wahrmann, Konstantin Doberer, Andreas Heilos, et al. 2020. “High-Activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-Specific Antibody-Triggered Injury and Renal Allograft Survival.” Transplantation Direct 6 (3): e534. doi:10.1097/TXD.0000000000000978.